Penumbra (PEN)
Builds clot-removal, embolization, and vascular-access devices for neurovascular and peripheral procedures.
$319.26
vs last close−0.13 (−0.04%)
Something off on this page? Send us feedback.
Next report
Nov 4, 26
in 42 days
EPS estimate
$1.20
Revenue estimate
$401.4M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25Apr '25Jul '25Nov '25Feb '26May '26Jul '26Nov '26
Reported$0.97$0.83$0.86$0.97$1.18$0.82$0.88Pending
Estimate$0.88$0.66$0.81$0.93$1.11$1.04$1.16$1.20
Surprise+10.2%+25.8%+6.2%+4.4%+6.3%−21.2%−24.1%—
RevenueReportedEstimate
Feb '25Apr '25Jul '25Nov '25Feb '26May '26Jul '26Nov '26
Reported$315.5M$324.1M$339.5M$354.7M$385.4M$374.8M$390.0MPending
Estimate$311.6M$327.3M$341.3M$341.0M$361.9M$370.5M$389.6M$401.4M
Surprise+1.2%−1.0%−0.6%+4.0%+6.5%+1.2%+0.1%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $1.98 | — | — |
| Sep 2028 | $1.95 | — | — |
| Jun 2028 | $1.82 | — | — |
| Mar 2028 | $1.50 | — | — |
| Dec 2027 | $1.85 | — | — |
| Sep 2027 | $1.57 | — | — |
| Jun 2027 | $1.48 | — | — |
| Mar 2027 | $1.43 | — | — |
| Dec 2026 | $1.48 | — | — |
| Nov 2026 | $1.20 | — | — |
| Jul 2026 | $1.16 | $0.88 | −24.1% |
| May 2026 | $1.04 | $0.82 | −21.2% |
| Feb 2026 | $1.11 | $1.18 | +6.3% |
| Nov 2025 | $0.93 | $0.97 | +4.4% |
| Jul 2025 | |||
| Apr 2025 | |||
| Feb 2025 | |||
| Oct 2024 | |||
| Jul 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Oct 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Sep 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $1.98 | — | — | $531.1M | — | — | — |
| Sep 2028 | $1.95 | — | — | $525.5M | — | — | — |
| Jun 2028 | $1.82 | — | — | $511.3M | — | — | — |
| Mar 2028 | $1.50 | — | — | $476.4M | — | — | — |
| Dec 2027 | $1.85 | — | — | $484.5M | — | — | — |
| Sep 2027 | $1.57 | — | — | $457.1M | — | — | — |
| Jun 2027 | $1.48 | — | — | $441.5M | — | — | — |
| Mar 2027 | $1.43 | — | — | $424.2M | — | — | — |
| Dec 2026 | $1.48 | — | — | $426.9M | — | — | — |
| Nov 4, 2026 | $1.20 | — | — | $401.4M | — | — | — |
| Jul 30, 2026 | $1.16 | $0.88 | −24.1% | $389.6M | $390.0M | +0.1% | +0.4% |
| May 6, 2026 | $1.04 | $0.82 | −21.2% | $370.5M | $374.8M | +1.2% | +0.1% |
| Feb 25, 2026 | $1.11 | $1.18 | +6.3% | $361.9M | $385.4M | +6.5% | +1.0% |
| Nov 5, 2025 | $0.93 | $0.97 | +4.4% | $341.0M | $354.7M | +4.0% | +17.3% |
| Jul 29, 2025 | |||||||
| Apr 23, 2025 | |||||||
| Feb 18, 2025 | |||||||
| Oct 30, 2024 | |||||||
| Jul 30, 2024 | |||||||
| May 7, 2024 | |||||||
| Feb 22, 2024 | |||||||
| Nov 2, 2023 | |||||||
| Aug 1, 2023 | |||||||
| May 2, 2023 | |||||||
| Feb 23, 2023 | |||||||
| Nov 3, 2022 | |||||||
| Aug 4, 2022 | |||||||
| May 3, 2022 | |||||||
| Feb 22, 2022 | |||||||
| Nov 3, 2021 | |||||||
| Aug 9, 2021 | |||||||
| May 4, 2021 | |||||||
| Feb 23, 2021 | |||||||
| Oct 28, 2020 | |||||||
| Aug 3, 2020 | |||||||
| May 7, 2020 | |||||||
| Feb 25, 2020 | |||||||
| Nov 7, 2019 | |||||||
| Aug 6, 2019 | |||||||
| May 7, 2019 | |||||||
| Feb 26, 2019 | |||||||
| Nov 5, 2018 | |||||||
| Aug 7, 2018 | |||||||
| May 8, 2018 | |||||||
| Feb 27, 2018 | |||||||
| Nov 7, 2017 | |||||||
| Aug 8, 2017 | |||||||
| May 9, 2017 | |||||||
| Feb 28, 2017 | |||||||
| Nov 3, 2016 | |||||||
| Aug 9, 2016 | |||||||
| May 9, 2016 | |||||||
| Mar 8, 2016 | |||||||
| Nov 12, 2015 | |||||||
| Sep 23, 2015 |